TSHZ3 expression, as one of five genes, was high in tongue SCC (Zeng et al., 2019) and TSHZ3 was duplicated in ovarian and triple negative breast cancers (McBride et al., 2012), while TSHZ3, as one of ten genes, inhibited the p53 activity in multiple non-small cell lung cancer cell lines (Van Olst et al., 2017). The gene discussed is TP53; the disease is triple-negative breast carcinoma.